Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sander

Showing results (311-320 of 351) with videos related to

Pageof 36
Sort By:
Frontiers in Immunology|December 5, 2025
Different kinetics of humoral response against individual antigens in the ovine model of <i>Toxoplasma gondii</i> infection and its pathological associationPaula Formigo, Ignacio Gual, Germán J Cantón, et al.
Journal of Biomechanical Engineering|January 25, 2024
A Systems Approach to Biomechanics, Mechanobiology, and BiotransportShayn M Peirce-Cottler, Edward A Sander, Matthew B Fisher, et al.
Scientific Reports|October 22, 2021
Superconducting imprint of magnetic textures in ferromagnets with perpendicular magnetic anisotropyA Sander, G Orfila, D Sanchez-Manzano, et al.
Journal of Translational Medicine|July 25, 2022
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitorsCindy A Sander, Elizabeth A Rush, Jian Shi, et al.
Nature Medicine|December 4, 2002
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune diseaseKamran Ghoreschi, Peter Thomas, Susanne Breit, et al.
Physical Review Letters|September 10, 2020
Long-Range Propagation and Interference of d-Wave Superconducting Pairs in GrapheneD Perconte, K Seurre, V Humbert, et al.
Cancer Cell|June 10, 2008
TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesisNele Müller-Hermelink, Heidi Braumüller, Bernd Pichler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Pharmacodynamic (phase 0) study using etaracizumab in advanced melanomaStergios J Moschos, Cindy A Sander, Wenjun Wang, et al.
BMC Cancer|June 12, 2022
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trialA Wick, A Sander, M Koch, et al.
Blood|June 24, 2009
Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammationManfred Kneilling, Reinhard Mailhammer, Lothar Hültner, et al.
Pageof 36

Showing results (311-320 of 351) with videos related to

Sort By:
Pageof 36
Frontiers in Immunology|December 5, 2025
Different kinetics of humoral response against individual antigens in the ovine model of <i>Toxoplasma gondii</i> infection and its pathological associationPaula Formigo, Ignacio Gual, Germán J Cantón, et al.
Journal of Biomechanical Engineering|January 25, 2024
A Systems Approach to Biomechanics, Mechanobiology, and BiotransportShayn M Peirce-Cottler, Edward A Sander, Matthew B Fisher, et al.
Scientific Reports|October 22, 2021
Superconducting imprint of magnetic textures in ferromagnets with perpendicular magnetic anisotropyA Sander, G Orfila, D Sanchez-Manzano, et al.
Journal of Translational Medicine|July 25, 2022
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitorsCindy A Sander, Elizabeth A Rush, Jian Shi, et al.
Nature Medicine|December 4, 2002
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune diseaseKamran Ghoreschi, Peter Thomas, Susanne Breit, et al.
Physical Review Letters|September 10, 2020
Long-Range Propagation and Interference of d-Wave Superconducting Pairs in GrapheneD Perconte, K Seurre, V Humbert, et al.
Cancer Cell|June 10, 2008
TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesisNele Müller-Hermelink, Heidi Braumüller, Bernd Pichler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Pharmacodynamic (phase 0) study using etaracizumab in advanced melanomaStergios J Moschos, Cindy A Sander, Wenjun Wang, et al.
BMC Cancer|June 12, 2022
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trialA Wick, A Sander, M Koch, et al.
Blood|June 24, 2009
Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammationManfred Kneilling, Reinhard Mailhammer, Lothar Hültner, et al.
Pageof 36